Drugs / 2,2'-DITHIODIETHANESULFONIC ACID
2,2'-DITHIODIETHANESULFONIC ACID
also known as
BNP7787 · BNP7787 also known as Tavocept · DIMESNA · LP-300 · NSC-716976 · NSC-760345 · Tavocept
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05456256 | Mar 2023 → Dec 2026 expected | lung adenocarcinoma | Lantern Pharma Inc. | Recruiting | No outcome recorded |
| Phase 2 | NCT00077311 | Aug 2004 → Jul 2006 | anemia, chemotherapy-induced toxicity, lung cancer, neutropenia | Alliance for Clinical Trials in Oncology | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00966914 Comparator | Apr 2010 → Apr 2013 | non-small cell lung carcinoma | BioNumerik Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00039780 Comparator | Sep 2001 → Oct 2006 | breast cancer, metastatic malignant neoplasm | BioNumerik Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2,2'-DITHIODIETHANESULFONIC ACID | ChEMBL registry synonym — accepted as the source's own label CHEMBL2009034 ↗ |
| Known as | BNP7787 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00077311 ↗ |
| Known as | BNP7787 also known as Tavocept | “BNP7787 also known as Tavocept” NCT00039780 ↗ |
| Known as | DIMESNA | ChEMBL registry synonym — accepted as the source's own label CHEMBL2009034 ↗ |
| Known as | LP-300 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05456256 ↗ |
| Known as | NSC-716976 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2009034 ↗ |
| Known as | NSC-760345 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2009034 ↗ |
| Known as | Tavocept | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00966914 ↗ |
| Modality | Small molecule | — CHEMBL2009034 ↗ |
| Route | Intravenous | “40 g IV over 30 min Day 1 of each cycle” NCT00077311 ↗ |